make notes based on uploaded pdf

Reading File
Running Command
Running Command
Running Command
I have all the content. Here are comprehensive notes:

πŸ“‹ Copper Poisoning β€” Notes (Biswas)

Chapter: Inorganic Metallic Irritants β€” Copper

πŸ”‘ Key Facts

  • Copper metal itself is not poisonous; body contains 100–150 mg copper
  • Functions as integral part of enzymes: catalase, cytochrome C oxidase, dopamine Ξ²-hydroxylase, serum ceruloplasmin
  • Copper must be supplied through diet as the body cannot synthesize it

πŸ’Š Toxic Compounds

CompoundDetails
Copper sulfate (blue vitriol, bluestone, nila tutia)Blue crystals, freely soluble; caustic/astringent taste; most common poison
Copper subacetate (verdigris)Blue-green compound; found on weathered brass/bronze/copper; used as fungicide
Copper carbonateBlue-green; part of verdigris patina
Uses of copper sulfate: molluscicide, plant fungicide, electroplating, preservation agent, precipitator; gastric and topical applications
Note: Copper sulfate acts both as poison and antidote (historically used as antidote in phosphorus poisoning and wound debridement)

βš™οΈ Mechanism of Action

  • Exerts toxicity on enzymes dependent on sulfhydryl and amino groups (high affinity for N and S donor ligands β€” same as other heavy metals)
  • Nucleic acids may also be targets
  • Copper ions oxidize heme iron β†’ methemoglobin β†’ cyanosis + chocolate brown colored blood

πŸ”„ Absorption & Excretion

  • Principal route: ingestion; also inhalation of dust/fumes (industrial/mining)
  • Absorbed mainly in stomach and jejunum
  • Bound to albumin β†’ transported to liver β†’ transferred to ceruloplasmin
  • Excreted mostly through feces (via bile)
  • Urinary excretion low: 25 Β΅g/24 hours
  • Organs affected (in order of severity): erythrocytes β†’ liver β†’ kidneys

🚨 Acute Poisoning β€” Signs & Symptoms

Onset: 15–30 minutes after ingestion
SystemSigns & Symptoms
GITMetallic taste, increased salivation (ptyalism), burning stomach pain, thirst, colicky abdominal pain, nausea, eructation, greenish-blue vomitus, hemorrhagic gastroenteritis
RenalOliguria, hematuria, hemoglobinuria, albuminuria, uremia
HepaticJaundice, tender hepatomegaly, hepatic encephalopathy
MSCramps/spasms of legs, paralysis of limbs, rhabdomyolysis
CVSBreathing difficulty, cold perspiration, methemoglobinemia, hypotension, tachycardia, circulatory collapse, shock
CNSFrontal headache, lethargy, drowsiness, insensibility, irreversible coma, death
Mnemonic β€” COPPER:
  • C – Colicky abdominal pain, Cramps, Circulatory shock, Coma
  • O – Oliguria
  • P – Paralysis of limbs
  • P – Perspiration (cold)
  • E – Emesis (greenish-blue), Eructation
  • R – Rhabdomyolysis
G-6-PD deficient individuals are at increased risk of hematologic effects

⚠️ Fatal Dose & Period

Copper subacetate15 g
Copper sulfate10–20 g (0.15–0.3 g/kg)
Fatal period18–24 hours (may extend to 1–3 days)

πŸ”¬ Diagnosis

  • Whole blood copper correlates better with severity than serum copper
  • Normal serum copper: 12–99 Β΅mol/L
  • Detection methods: neutron activation analysis, atomic absorption spectroscopy, merocyanine dye (fluorescence spectroscopy)

πŸ’‰ Treatment

StepDetail
No emeticsVomiting occurs spontaneously in 5–10 min; emetics risk re-exposure of esophagus
Gastric lavage1% potassium ferrocyanide β†’ forms insoluble cupric ferrocyanide; plain water if unavailable
DemulcentsEgg white or milk (form insoluble albuminate of copper); sucralfate for mucosal injury
Castor oilRemoves poison from intestines
MethemoglobinemiaMethylene blue 1–2 mg/kg of 1% solution IV over 5 min
Chelation (1st choice)D-penicillamine (chelator of choice); alternatives: DMSA, DMPS (hydrophilic dithiol chelators β€” more efficient), EDTA, BAL
PainMorphine injection
HypotensionFluids, dopamine, noradrenaline
Severe casesHydrocortisone 50–100 mg IM TDS (for anorexia + hematuria; routine steroid use is doubtful)
HemodialysisIneffective for copper removal; may be indicated for renal failure
Tetrathiomolybdate β€” suggested chelating agent; enhances urinary excretion via increased molybdenum intake

πŸ” Postmortem Findings

External:
  • Skin may be yellow (jaundice)
  • Greenish-blue froth from mouth and nostrils
  • Mucous membranes of mouth, tongue β†’ bluish/greenish-blue tinge
Internal:
  • Bluish/greenish-blue discoloration of esophagus, stomach, intestinal mucosa
  • Caustic burns of esophagus; superficial and deep ulcers in stomach/small intestine
  • Stomach: congested gastric mucosa, desquamation, hemorrhages
  • Small intestine: upper part mucosal necrosis
  • Liver: soft, fatty; centrilobular necrosis and biliary stasis
  • Kidneys: acute proximal tubular necrosis; hemoglobin casts in tubules

πŸ•°οΈ Chronic Copper Poisoning

Causes:
  • Acidic foods cooked in uncoated copper cookware
  • Excess copper in drinking water / food contaminated with verdigris
  • Occupational: inhalation of copper dust or fumes (welders β†’ metal fume fever)
Signs & Symptoms:
  1. Green/purple line on gums; constant metallic taste; nausea, dyspepsia, vomiting, diarrhea
  2. Bluish-green discoloration
  3. Renal damage
  4. Progressive emaciation, anemia, malaise, weight loss
  5. Peripheral neuritis with wrist drop or foot drop; muscle atrophy
  6. Copper dust β†’ conjunctival inflammation and corneal ulceration
  7. Skin becomes jaundiced
  8. Urine and perspiration become greenish
  9. Bronze diabetes may be present
Treatment: Remove cause; fresh air; massage and warm bath; symptomatic treatment
PM Findings (Chronic): Fatty degeneration of liver; degeneration of renal tubular epithelium

πŸ›οΈ Medico-Legal Aspects

  • Suicidal cases are common
  • Accidental poisoning: from food contaminated with verdigris (vegetable acids acting on copper cookware)
  • Systemic absorption possible from copper IUCDs or hemodialysis tubing
  • Homicide: rare, because of characteristic color and metallic taste
  • Copper added to vegetables to preserve green color β†’ poisoning
  • Children may swallow copper sulfate crystals attracted by the color
  • Rarely used as cattle poison

πŸ‘οΈ Special Conditions

Chalcosis Oculi

  • Chronic ophthalmic exposure to elemental copper/alloys β†’ deposition in cornea, lens, vitreous, retina
  • Kayser-Fleischer ring β€” golden brown/ruby red/green pigment ring in peripheral Descemet's membrane
  • Chalcosis lentis β€” anterior subcapsular cataract ("sunflower cataract," typically greenish)

Vineyard Sprayer's Lung

  • Occupational disease in Portuguese vineyard workers
  • Cause: chronic exposure to Bordeaux solution (1–2% copper sulfate + lime)
  • Pathology: interstitial pulmonary fibrosis + histiocytic granulomas containing copper
  • Radiology: resembles silicosis β€” micronodular early, progressive massive fibrosis late
  • Other causes of pulmonary fibrosis: paraquat, organophosphates

πŸ“Œ Key One-Liners for Exams

  • Copper content in body: 100–150 mg
  • Color of vomitus in acute poisoning: greenish-blue
  • Chelator of choice: D-penicillamine
  • Copper sulfate is both a poison and antidote
  • Methemoglobinemia mechanism: copper ions oxidize heme iron
  • PM finding: greenish-blue froth from mouth and nostrils
  • Sunflower cataract = chalcosis lentis
  • Kayser-Fleischer ring = copper deposition in Descemet's membrane

make pathophysiology of acute myocardial infarction in flowchart from harrison only

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive pathophysiology content directly from Harrison's. Here is the complete flowchart based exclusively on Harrison's Principles of Internal Medicine 22E:

πŸ«€ Pathophysiology of Acute Myocardial Infarction

Based on Harrison's Principles of Internal Medicine, 22nd Edition (2025)


╔══════════════════════════════════════════════════════════════════╗
β•‘          ATHEROSCLEROTIC CORONARY ARTERY DISEASE (CAD)          β•‘
β•‘   Lipid-rich core + thin fibrous cap = "Vulnerable Plaque"      β•‘
β•‘   (eccentric stenosis with scalloped/overhanging edges)         β•‘
β•šβ•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•¦β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•
                           β”‚
          β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
          β–Ό                β–Ό                β–Ό
  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β” β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β” β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
  β”‚ PLAQUE FISSUREβ”‚ β”‚   PLAQUE    β”‚ β”‚   PLAQUE EROSION β”‚
  β”‚ WITH          β”‚ β”‚  FISSURE    β”‚ β”‚ (β‰₯1/3 of all ACS)β”‚
  β”‚ INFLAMMATION  β”‚ β”‚  WITHOUT    β”‚ β”‚                  β”‚
  β”‚               β”‚ β”‚ INFLAMMATIONβ”‚ β”‚                  β”‚
  β”‚ ↑ Effector T  β”‚ β”‚             β”‚ β”‚                  β”‚
  β”‚ cells (adaptiveβ”‚ β”‚            β”‚ β”‚                  β”‚
  β”‚ immunity      β”‚ β”‚             β”‚ β”‚                  β”‚
  β”‚ dysregulation)β”‚ β”‚             β”‚ β”‚                  β”‚
  β””β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”˜ β””β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”˜ β””β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
          β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
                           β–Ό
╔══════════════════════════════════════════════════════════════════╗
β•‘         EXPOSURE OF THROMBOGENIC MATERIAL IN PLAQUE CORE        β•‘
β•‘              TO CIRCULATING BLOOD COMPONENTS                    β•‘
β•šβ•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•¦β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•
                           β”‚
          β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
          β–Ό                β–Ό                 β–Ό
  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
  β”‚   PLATELET   β”‚  β”‚    FIBRIN   β”‚  β”‚  VASOCONSTRICTIONβ”‚
  β”‚  AGGREGATION β”‚  β”‚  FORMATION  β”‚  β”‚  (coronary spasm)β”‚
  β””β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”˜  β””β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”˜  β””β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”˜
         β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”Όβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
                            β–Ό
╔══════════════════════════════════════════════════════════════════╗
β•‘           PLATELET-RICH ARTERIAL THROMBUS FORMATION             β•‘
β•‘     (arterial thrombi are white and platelet-rich due to        β•‘
β•‘           high shear in injured arteries)                       β•‘
β•šβ•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•¦β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•
                           β”‚
         β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
         β–Ό                                    β–Ό
 β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”               β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
 β”‚  PARTIAL CORONARY β”‚               β”‚  COMPLETE CORONARY β”‚
 β”‚    OCCLUSION      β”‚               β”‚    OCCLUSION       β”‚
 β”‚ (non-occlusive    β”‚               β”‚  (occlusive        β”‚
 β”‚   thrombus)       β”‚               β”‚   thrombus)        β”‚
 β””β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜               β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
          β–Ό                                     β–Ό
 β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”             β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
 β”‚  NSTE-ACS           β”‚             β”‚  STEMI                 β”‚
 β”‚  β€’ Unstable Angina  β”‚             β”‚ (ST-segment elevation  β”‚
 β”‚    (no troponin rise)β”‚            β”‚  MI β€” transmural)      β”‚
 β”‚  β€’ NSTEMI           β”‚             β”‚                        β”‚
 β”‚    (troponin +ve,   β”‚             β”‚                        β”‚
 β”‚    subendocardial   β”‚             β”‚                        β”‚
 β”‚    necrosis)        β”‚             β”‚                        β”‚
 β””β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜             β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
          β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”¬β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
                             β–Ό
╔══════════════════════════════════════════════════════════════════╗
β•‘       IMBALANCE: MYOCARDIAL Oβ‚‚ SUPPLY < DEMAND                  β•‘
β•šβ•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•¦β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•
                           β–Ό
╔══════════════════════════════════════════════════════════════════╗
β•‘               MYOCARDIAL ISCHEMIA                               β•‘
β•‘  β€’ Lowered resting membrane potential                           β•‘
β•‘  β€’ Shortened action potential duration                          β•‘
β•‘  β€’ Voltage gradient between normal & ischemic zones            β•‘
β•‘  β€’ "Currents of injury" β†’ ST deviations on ECG                  β•‘
β•šβ•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•¦β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•
                           β–Ό
╔══════════════════════════════════════════════════════════════════╗
β•‘                  PROGRESSIVE CELL DEATH                         β•‘
β•‘                (Irreversible necrosis)                          β•‘
β•‘  Order of vulnerability: Erythrocytes β†’ Subendocardium first    β•‘
β•‘  ("wavefront phenomenon" β€” inner to outer layers)               β•‘
β•šβ•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•¦β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•β•
                           β–Ό
         β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
         β–Ό                                    β–Ό
╔═════════════════════╗              ╔═══════════════════════════╗
β•‘  LV DYSFUNCTION     β•‘              β•‘  NEUROHUMORAL ACTIVATION  β•‘
β•‘  β€’ ↓ Contractility  β•‘              β•‘  β€’ ↑ Sympathetic tone     β•‘
β•‘  β€’ Regional wall    β•‘              β•‘  β€’ ↑ Catecholamines       β•‘
β•‘    motion abnorm.   β•‘              β•‘  β€’ ↑ RAAS activation      β•‘
β•‘  β€’ ↑ LVEDP          β•‘              β•‘  β€’ ↑ AVP (vasopressin)    β•‘
β•‘  β€’ ↓ Stroke volume  β•‘              β•šβ•β•β•β•β•β•β•β•β•β•β•β•β•β•β•¦β•β•β•β•β•β•β•β•β•β•β•β•β•
β•‘  β€’ ↓ Cardiac output β•‘                             β”‚
β•šβ•β•β•β•β•β•β•β•β•β•β•¦β•β•β•β•β•β•β•β•β•β•β•                             β–Ό
           β”‚                         β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
           β–Ό                         β”‚  Tachycardia, vasoconstrictionβ”‚
  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”    β”‚  Na⁺/Hβ‚‚O retention          β”‚
  β”‚     COMPLICATIONS           β”‚    β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜
  β”‚                             β”‚
  β”‚  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”    β”‚
  β”‚  β”‚  ELECTRICAL         β”‚    β”‚
  β”‚  β”‚  β€’ VF/VT (most      β”‚    β”‚
  β”‚  β”‚    common early     β”‚    β”‚
  β”‚  β”‚    cause of death)  β”‚    β”‚
  β”‚  β”‚  β€’ Heart block      β”‚    β”‚
  β”‚  β”‚  β€’ Atrial fibrillationβ”‚  β”‚
  β”‚  β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜    β”‚
  β”‚                             β”‚
  β”‚  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”    β”‚
  β”‚  β”‚  MECHANICAL         β”‚    β”‚
  β”‚  β”‚  β€’ Cardiogenic shockβ”‚    β”‚
  β”‚  β”‚  β€’ Acute MR (papillaryβ”‚  β”‚
  β”‚  β”‚    muscle rupture)  β”‚    β”‚
  β”‚  β”‚  β€’ VSD (septal      β”‚    β”‚
  β”‚  β”‚    rupture)         β”‚    β”‚
  β”‚  β”‚  β€’ Free wall ruptureβ”‚    β”‚
  β”‚  β”‚  β€’ LV aneurysm      β”‚    β”‚
  β”‚  β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜    β”‚
  β”‚                             β”‚
  β”‚  β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”    β”‚
  β”‚  β”‚  ISCHEMIC           β”‚    β”‚
  β”‚  β”‚  β€’ Extension of MI  β”‚    β”‚
  β”‚  β”‚  β€’ Recurrent        β”‚    β”‚
  β”‚  β”‚    ischemia         β”‚    β”‚
  β”‚  β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜    β”‚
  β””β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”˜

πŸ“Œ Key Pathophysiologic Steps β€” Summary Table

StepMechanism (Harrison's)
Vulnerable plaqueLipid-rich core + thin fibrous cap; eccentric stenosis on angiography
Plaque disruption triggers(1) Fissure with inflammation (↑ effector T cells), (2) Fissure without inflammation, (3) Erosion (β‰₯1/3 of cases)
Thrombus typePlatelet-rich (white) β€” due to high arterial shear forces
Partial occlusion β†’ NSTE-ACSNon-occlusive thrombus β†’ UA (no necrosis) or NSTEMI (subendocardial necrosis, troponin +ve)
Complete occlusion β†’ STEMIOcclusive thrombus β†’ transmural ischemia β†’ full-thickness infarction
Ischemia β€” electrophysiology↓ Resting membrane potential, ↓ action potential duration β†’ "currents of injury" β†’ ST changes
STEMI ECG patternTransmural ischemia: ST vector directed outward β†’ ST elevation in overlying leads; hyperacute T waves early
NSTEMI ECG patternSubendocardial: ST vector toward cavity β†’ ST depression; ST elevation in aVR
Necrosis progressionSubendocardium most vulnerable (reduced coronary driving pressure + increased compressive forces)
Oβ‚‚ demand-supply imbalanceFixed epicardial obstruction + dynamic vasoconstriction/spasm amplifies ischemia

πŸ”„ STEMI vs NSTEMI Pathophysiology at a Glance

     Atherosclerotic Plaque Disruption
              β”‚
    β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”
    β”‚                    β”‚
OCCLUSIVE            NON-OCCLUSIVE
THROMBUS              THROMBUS
    β”‚                    β”‚
Transmural          Subendocardial
 Ischemia            Ischemia
    β”‚                    β”‚
ST ELEVATION      ST Depression /
  (STEMI)         No ST change
    β”‚               (NSTE-ACS)
Full-thickness      β”‚
  Necrosis      β”Œβ”€β”€β”€β”΄β”€β”€β”€β”
             No necrosis   Necrosis
           (Unstable      (NSTEMI β€”
            Angina)      Troponin +ve)

Source: Harrison's Principles of Internal Medicine, 22nd Edition (2025), Chapters 247, 285, 286 β€” McGraw Hill Medical
This is a shared conversation. Sign in to Orris to start your own chat.